REFERENCES
Almeida, J. R. C. de et al. (2009) Abnormal Amygdala-
Prefrontal Effective Connectivity to Happy Faces
Differentiates Bipolar from Major Depression.
Biological Psychiatry, 66: 451–459.
Angst, J. (1998) The emerging epidemiology of hypomania
and bipolar II disorder. Journal of Affective Disorders,
50: 143–151.
Angst, J., Sellaro, R. (2000) Historical perspectives and
natural history of bipolar disorder. Biological
Psychiatry, 48: 445–457.
Benazzi, F. (2007) Bipolar II Disorder. CNS Drugs, 21:
727–740.
Carbon, M., Hsieh, C.-H., Kane, J. M. & Correll, C. U.
(2017) Tardive Dyskinesia Prevalence in the Period of
Second-Generation Antipsychotic Use: A Meta-
Analysis. The Journal of Clinical Psychiatry, 78: e264-
78.
Carkaci-Salli, N. et al. Functional characterization of the
S41Y (C2755A) polymorphism of tryptophan
hydroxylase 2. (2014) Journal of Neurochemistry, 130:
748–758.
Escamilla, M. A., Zavala, J. M. (2008) Genetics of bipolar
disorder. Dialogues Clinical Neuroscience, 10: 141–
152.
Frye, M. A. et al. (2015) Feasibility of investigating
differential proteomic expression in depression:
implications for biomarker development in mood
disorders. Translational Psychiatry, 5: e689.
Geddes, J. R., Miklowitz, D. J. (2013) Treatment of bipolar
disorder. The Lancet, 381: 1672–1682.
Grande, I., Berk, M., Birmaher, B., Vieta, E. (2016) Bipolar
disorder. The Lancet, 387: 1561–1572.
Hoffman, M., MD. An Overview of Bipolar II Disorder.
WebMD https://www.webmd.com/bipolar-
disorder/guide/bipolar-2-disorder.
IsHak, W. W., Brown, K., Aye, S. S., Kahloon, M.,
Mobaraki, S, Hanna R. (2012) Health-related quality of
life in bipolar disorder. Bipolar Disorders, 14: 6–18.
Jann, M. W. (2014) Diagnosis and Treatment of Bipolar
Disorders in Adults: A Review of the Evidence on
Pharmacologic Treatments. Am Health Drug Benefits,
7: 489–499.
Jauhar, S., Young, A. H. (2019) Controversies in bipolar
disorder; role of second-generation antipsychotic for
maintenance therapy. International Journal of Bipolar
Disorders, 7: 10.
Judd, L. L. et al. (2002) The Long-term Natural History of
the Weekly Symptomatic Status of Bipolar I Disorder.
Archives of General Psychiatry, 59: 530–537.
Lee, S. Y. et al. (2021) Identification of potential plasma
protein biomarkers for bipolar II disorder: a
preliminary/exploratory study. Scientific Reports, 11:
9452.
Lin, Y. M. J. et al. (2007) Association of functional
polymorphisms of the human tryptophan hydroxylase 2
gene with risk for bipolar disorder in Han Chinese.
JAMA Psychiatry, 64: 1015–1024.
Macritchie, K. A. N. et al. (2010) White matter
microstructural abnormalities in euthymic bipolar
disorder. The British Journal of Psychiatry, 196: 52–58.
Maina, G., Bertetto, N., Boccolini, F. D., Salvo, G. D.,
Rosso, G., Bogetto, F. (2013) The concept of mixed
state in bipolar disorder: from Kraepelin to DSM-5.
Official Journal of the Italian Society of
Psychopathology, 19: 287–295.
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., Berk,
M. (2013) Potential Mechanisms of Action of Lithium
in Bipolar Disorder: Current Understanding. CNS
Drugs, 27: 135–153.
Mason, B. L., Brown, E. S., Croarkin, P. E. (2016)
Historical Underpinnings of Bipolar Disorder
Diagnostic Criteria. Behav Sci (Basel), 6: 14.
Mayo Clinic Staff. Bipolar disorder - Symptoms and
causes. Mayo Clinic
https://www.mayoclinic.org/diseases-
conditions/bipolar-disorder/symptoms-causes/syc-
20355955.
Michalak, E. E., Yatham, L. N., Kolesar, S., Lam, R. W.
(2006) Bipolar Disorder and Quality of Life: A Patient-
Centered Perspective. Qual Life Res, 15: 25–37.
Müller-Oerlinghausen, B., Berghöfer, A., Bauer, M. (2002)
Bipolar disorder. The Lancet, 359: 241–247.
Phillips, M. L., Kupfer, D. J. (2013) Bipolar disorder
diagnosis: challenges and future directions. The Lancet,
381: 1663–1671.
Pompili, M. et al. (2013) Epidemiology of suicide in bipolar
disorders: a systematic review of the literature. Bipolar
Disorders, 15: 457–490.
Rajput, A. H. (1975) Drug Therapy in Common
Neurological Disorders. Canadian Family Physician,
21: 52–56.
Torrent, C. et al. (2006) Cognitive impairment in bipolar II
disorder. The British Journal of Psychiatry, 189: 254–
259.
Van Meter, A. R., Youngstrom, E. A., Findling, R. L.
(2012) Cyclothymic disorder: A critical review.
Clinical Psychology Review, 32: 229–243.
Zhang, X., Beaulieu, J. M., Gainetdinov, R. R., Caron, M.
G. (2006) Functional polymorphisms of the brain
serotonin synthesizing enzyme tryptophan hydroxylase
2. Cellular and Molecular Life Science, 63: 6–11.